A Virtual Network to Investigate the Clinical Epidemiology of Influenza and the Effectiveness of Influenza Vaccines

<p>Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for <em>a California-based integrated health care system to serve as an electronic health record site in CDC&rsquo;s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings</em>. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is <em>541380-</em> <em>Testing Laboratories and Services</em>.</p>

Point of Contact

• Debra Baker — xvv9@cdc.gov — 404.498.4855
• Liubov Kriel — riseridiq@cdc.gov — 7704882856

View on SAM.gov

https://sam.gov/workspace/contract/opp/71915a7ca3cf474c99e2c11a87b00e75/view